Who owns PACIRA BIOSCIENCES?
- CUSIP Number: 695127af7
Tip: Access positions for across all investors
Analyze quarterly positions in Pacira Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pacira Biosciences stock
Who bought or sold PACIRA BIOSCIENCES this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Osterweis Capital Management | 29M | $28M | 100% | Dec 2024 |
|
| Linden Advisors | 26M | $25M | 100% | Dec 2024 |
|
| Tenor Capital Management | 21M | $20B | 0% | Dec 2024 |
|
| Lazard Asset Management | 20M | $20M | 12% | Dec 2024 |
|
| Opti Capital Management | 19M | $18B | 0% | Dec 2024 |
|
| Wellesley Investment Advisors | 12M | $12B | -17% | Dec 2024 |
|
| Radcliffe Capital Management | 11M | $11B | 0% | Dec 2024 |
|
| Capstone Investment Advisors | 11M | $11M | 0% | Dec 2024 |
|
| FMR | 10M | $9.7M | 100% | Dec 2024 |
|
| D. E. Shaw & Co | 7.7M | $7.4M | 0% | Dec 2024 |
|
| Palisade Capital Management | 7.0M | $6.8M | 28% | Dec 2024 |
|
| Oaktree Capital Management | 4.6M | $4.5M | -29% | Dec 2024 |
|
| Aristeia Capital | 4.0M | $3.9M | 0% | Dec 2024 |
|
| Aequim Alternative Investments | 3.3M | $3.2M | 0% | Dec 2024 |
|
| Highbridge Capital Management | 2.5M | $2.4M | -80% | Dec 2024 |
|
| Piper Jaffray & Co. | 2.2M | $2.1B | 8% | Dec 2024 |
|
| Russell Investments | 2.1M | $2.0M | -30% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.5M | $1.5M | 100% | Dec 2024 |
|
| UBS Group | 1.2M | $1.2M | 100% | Dec 2024 |
|
| Calamos Advisors | 1.0M | $1.0M | -5% | Dec 2024 |
|
| Wells Fargo & Company | 746k | $722k | 0% | Dec 2024 |
|
| Commonwealth of Pennsylvania | 530k | $514k | 0% | Dec 2024 |
|
| Citigroup | 484k | $469k | 90% | Dec 2024 |
|
| Zazove Associates | 400k | $388k | 0% | Dec 2024 |
|
| Leucadia National Corporation | 252k | $245k | 157% | Dec 2024 |
|
| Cetera Investment Advisers | 123k | $119k | -15% | Dec 2024 |
|
| Argent Trust | 36k | $35k | 0% | Dec 2024 |
|
| SFMG Wealth Advisors | 24k | $23k | 0% | Dec 2024 |
|
| Rsm Us Wealth Management | 23k | $22k | 0% | Dec 2024 |
|
| J.w. Cole Advisors | 18k | $17k | 0% | Dec 2024 |
|
| Kestra Advisory Services | 16k | $1.6M | 100% | Dec 2024 |
|
| Bank of America Corporation | 15k | $15k | 0% | Dec 2024 |
|
| Boston Financial Mangement | 12k | $12k | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 11k | $11k | -100% | Dec 2024 |
|
| Asset Dedication | 10k | $9.7k | 0% | Dec 2024 |
|
| Sensible Money | 10k | $9.7k | 0% | Dec 2024 |
|
| MAI Wealth Advisors | 10k | $9.7k | 100% | Dec 2024 |
|
Who sold out of Pacira Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Daiwa Securities Group | Sep 2024 | 6.0M | $5.7M |
| Context Capital Management | Sep 2024 | 19k | $18M |